Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$30.8M Sell
576,522
-33,830
-6% -$1.74M 1.3% 30
2019
Q2
$30.5M Buy
610,352
+6,595
+1% +$331K 1.3% 33
2019
Q1
$31.5M Buy
603,757
+30,967
+5% +$1.55M 1.36% 31
2018
Q4
$27.4M Buy
572,790
+92,876
+19% +$4.57M 1.31% 25
2018
Q3
$24.1M Buy
479,914
+39,424
+9% +$2M 1.01% 36
2018
Q2
$22.2M Buy
+440,490
New +$22.2M 0.97% 40
2017
Q4
Sell
-13,004
Closed -$660K 213
2017
Q3
$660K Buy
13,004
+8,663
+200% +$440K 0.03% 127
2017
Q2
$234K Buy
+4,341
New +$231K 0.01% 191

Other funds holding GSK

South Texas Money Management's GSK Position: Q3 2019 in Review

South Texas Money Management reduced its GSK (GSK) stake by 5.5% in Q3 2019, selling an estimated $1.74M and leaving 576,522 shares worth $30.8M. The position accounts for 1.3% of the portfolio, ranked #30.

South Texas Money Management first reported a position in GSK in Q2 2017 and has held it in 8 quarters since. The position peaked at $31.5M in Q1 2019. 806 funds tracked by Wall St. Rank hold GSK as of Q3 2019.

  • South Texas Money Management held 576,522 shares of GSK worth $30.8M as of Q3 2019.
  • South Texas Money Management sold 33,830 GSK shares in Q3 2019, an estimated $1.74M.
  • GSK made up 1.3% of South Texas Money Management's portfolio in Q3 2019, its #30 holding.
  • South Texas Money Management first reported a position in GSK in Q2 2017 and has held it in 8 quarters since.
  • South Texas Money Management's GSK position peaked at $31.5M in Q1 2019.
  • 806 funds tracked by Wall St. Rank held GSK as of Q3 2019.

Based on South Texas Money Management's 13F filing for Q3 2019, filed 13 Nov 2019.